* Patients can try NITYR for three weeks for free as long as their doctor prescribes it. Subject to terms and conditions, eligibility criteria, and to other federal and state law.

See offer

* For eligible commercially insured patients. Doctor’s prescription required. Subject to terms and conditions and eligibility criteria. Program not available for government-insured patients and subject to other federal and state law.

See offer
+
This site is intended for US healthcare professionals NITYR Back to top
Safety InformationPrescribing Information

News

24 Patients Now Receiving NITYR in the US

Following the launch of NITYR (nitisinone) tablets in the US last year, we are delighted to announce that 24 patients…

Cycle Pharmaceuticals Receives Approval for Updated Infant Administration for…

Cycle Pharmaceuticals (Cycle) is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved a…

Sign up for updates

Please click the button below and fill out the form to sign up to updates from our newsletter.

Sign up

Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted…

Cycle Pharmaceuticals (Cycle) is pleased to announce that it has obtained the required stability data to extend the…

Boston, US. Office Opens

We are pleased to announce that we have opened new offices in Boston, Mass., US. The new offices will act as a base for…

x OPEN

Sign up for updates

Speciality